Pancreatic Ductal Adenocarcinoma: Current and Emerging Therapeutic Uses of Focused Ultrasound

Pancreatic Ductal Adenocarcinoma: Current and Emerging Therapeutic Uses of Focused Ultrasound

Pancreatic ductal adenocarcinoma (PDAC) diagnosis accompanies a somber prognosis for the patient, with dismal survival odds: 5% at 5 years. Despite extensive research, PDAC is expected to become the second leading cause of mortality by cancer by 2030. Ultrasound (US) has been used successfully in tr...

Full description

Bibliographic Details
Main Authors: Maxime Lafond, Thomas Lambin, Robert Andrew Drainville, Aurélien Dupré, Mathieu Pioche, David Melodelima, Cyril Lafon
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Cancers
Subjects:
PDAC
focused ultrasound
HIFU
cavitation
drug delivery
sonodynamic therapy
Online Access:https://www.mdpi.com/2072-6694/14/11/2577

Internet

https://www.mdpi.com/2072-6694/14/11/2577

Similar Items